Zota Health Care's PAT for Q3 at Rs550.14 lakh, stock remains flat

18 Feb 2022 , 12:18 PM

Zota Health Care Ltd. reported its results for the quarter and nine months ended December 2021 and has logged marginal 15% yoy growth in its revenue for the quarter at Rs3,093.88 lakh against Rs3,048.27 lakh in the quarter ended December 2020. Whereas, for the 9M ended December 2021, revenue jumped 30.95% yoy at Rs9978.07 lakh against Rs7619.86 lakh for 9M ended December 2021.

The company reported its EBITDA at Rs550.14 lakh for Q3FY22 against a negative EBITDA of Rs61.51 lakh, registering a growth of a whopping
994% yoy.

Its PAT for the quarter under review stood at Rs354.63 lakh as compared to a loss of Rs100.76 lakh in the quarter ended December 2020, substantially up by 452% yoy.

PAT for the 9 months ended December 2021 also grew by a whopping 1874% yoy at Rs1023.27 lakh against Rs51.82 lakh in the previous 9 months ended December 2020.

EBITDA margin widened sharply to 15.34% for the quarter ended December 2021, as compared to a negative EBITDA margin of 4.64% for the quarter ended December 2020. PAT margin stood at 11.45% for Q3FY22 against -3.31% for Q3FY21.

Zota Healthcare dipped 0.21% or 75 paise in today’s trade at Rs361.75 against its previous closing price of Rs362.50. It touched day’s high and low of Rs365.50 and Rs358.65 so far, hinting a neutral outlook.